查詢結果分析
相關文獻
- The Clinical Pictures and Survival Analysis of Colorectal Cancer Patients Less Than or Equal to 40 Years of Age--Data from a Single Hospital
- 大腸直腸癌篩檢簡介
- Irinotecan (Campto[feb9])--治療大腸直腸癌的新藥
- 大腸直腸癌的流行病學特徵及可能之成因
- 大腸直腸癌症病患生活品質及其相關因素之探討
- Colonoscopic Surveillance in Asymptomatic Persons with Family History of Colorectal Cancer
- 大腸直腸癌術後肺臟轉移之手術治療
- 大腸直腸癌化學治療之近況
- Relationship between Size of Colorectal Cancer and Treatment: A Comparative Study
- The Clinical Features of HNPCC
頁籤選單縮合
| 題 名 | The Clinical Pictures and Survival Analysis of Colorectal Cancer Patients Less Than or Equal to 40 Years of Age--Data from a Single Hospital=小於或等於40歲大腸直腸癌患者之臨床表現及存活分析:來自單一醫院的資料 |
|---|---|
| 作 者 | 呂敏吉; 林哲斌; 丁金聰; 陳光宏; 鄭企峰; | 書刊名 | 臺灣癌症醫學雜誌 |
| 卷 期 | 2:3 2015.09[民104.09] |
| 頁 次 | 頁205-212 |
| 分類號 | 416.245 |
| 關鍵詞 | 大腸直腸癌; 小於40歲; KRAS突變; Colorectal cancer; Less than 40 years old; KRAS mutation; |
| 語 文 | 英文(English) |
| 中文摘要 | 目的:評估小於等於40歲的大腸直腸癌的臨床表現及存活率。方法:收集本院自2007年一月到2012年十二月共819位大腸直腸癌的病人,其中23位(2.8%)小於等於40歲。分析臨床表現及存活率,並與大於40歲大腸直腸癌的病患做相關探討。結果:在小於等於40歲和大於40歲的大腸直腸癌中,在性別、分期、組織學等級、KRAS突變率並無差異;甚至在組織學上特殊的黏液性癌方面,小於40歲為8.3%而大於40歲為3.5%,但無統計學上意義(p=0.219)。而在存活率分析方面,在同一個期別小於等於40歲和大於40歲的大腸直腸癌,兩者存活率並無不同。結論:無論在臨床表現及存活率,在小於40歲或大於40歲的大腸直腸癌並無差異。 |
| 英文摘要 | Purpose: The purpose of our study was to evaluate the clinical features and survival of colorectal cancer patients 40 years of age and under. Patients and Methods: From January 1, 2007 to December 31, 2012, a total of 819 colorectal cancer patients were admitted to our hospital, of which 23 cases (2.8%) were equal to or less than 40 years of age. We analyzed their clinical pictures and compared their prognoses to that of their colorectal cancer counterparts older than 40 years of age. Results: The gender distribution, staging, histological grading, and KRAS mutation rate showed no difference between the two groups. Even the incidence of mucinous carcinoma with special histology was 8.3% ( in<40 age group) vs. 3.5% (in>40 age group), without statistical significance (p=0.219). Overall, the survival analysis demonstrated there to be no difference in each stage between patients 40 years of age and under, and those patients over 40 years of age. Conclusions: There was no difference in the clinical features and survival duration of colorectal cancer patients between those patients less than 40 years of age and those more than 40 years of age. |
本系統中英文摘要資訊取自各篇刊載內容。